Flu Vaccine: Manufactures & Market Analysis

Over the recent years, the Influenza Vaccine market has witnessed double digit growth rate due to fear of an impending pandemic. The Influenza Vaccine market has grown at a CAGR of approximately 65% between 2008 and 2010 due to the havoc caused by H1N1 virus. However, H1N1 vaccine demand will decline due to waning threat of swine flu epidemic. The Influenza Vaccine market is expected to cross USD 4 billion in 2015. Among all the geographical regions, U.S. was the largest Influenza Vaccine market in the year 2010 closely followed by China. Top six players of influenza vaccine manufacturers occupy more than 75% of the total influenza vaccine market. Seasonal influenza vaccine brands like Fluarix & Flulaval were one of the leading players in the market in 2010. Other key players in this market include GlaxoSmithKline, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Sinovac Biotech and Hualun Biologicals. Incase of Pediatric flu vaccine Starting in 2014-2015, CDC recommends use of the nasal spray vaccine (LAIV) for healthy children 2 through 8 years of age, when it is immediately available and if the child has no contraindications or precautions to that vaccine. Recent studies suggest that the nasal spray flu vaccine may work better than the flu shot in younger children.

Influenza vaccine constitutes a significant segment of overall vaccine market. The large public attention associated with Influenza A (H1N1, swine flu) pandemic in 2009, growing health awareness in emerging countries has played a significant role in determining the dynamics of the global influenza market. Generally, trivalent flu vaccine are available which protects against two influenza A viruses (an H1N1 and an H3N2) and an influenza B virus. After that quadrivalent vaccines available, which contain two influenza B strains along with the standard two A strains (H1N1 and H3N2). The aim of including two B strains is to provide protection against both of the type B lineages, which circulate in varying and unpredictable proportions. The quadrivalent flu vaccine is designed to protect against four different flu viruses; two influenza A viruses and two influenza B viruses.included an influenza A H1N1 virus, an influenza A H3N2 virus and one B virus. The researchers in the new study were able to formulate a vaccine that created antibodies from the stem. The vaccines showed success among a variety of lab animals including mice, ferrets and monkeys and protected against flu strains like H5N1 avian flu and H1N1 (swine flu). Scientists are one step closer to developing a universal flu vaccine to protect against all strains of the virus.

  • Case reports from vaccine manufacturers
  • H1N1 vaccine and market analysis
  • Pediatric flu vaccine and market analysis
  • Respiratory flu vaccine and market analysis
  • Bioprocess in influenza vaccine production
  • Designing tools for influenza vaccine production
  • Innovative vaccine manufacturing technologies using plant as bioreactor

Related Conference of Flu Vaccine: Manufactures & Market Analysis

October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
November 06-07, 2017

3rd International Conference on Flu and Emerging Infectious Diseases

Las Vegas, Nevada, USA
December 07-08, 2017

EuroSciCon Conference on STD-AIDS

Rome, Italy
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
June 11-12, 2018

4th World Congress on Rare Diseases and Orphan Drugs

Dublin, Ireland
July 23-25, 2018

11th World Congress on Infectious Diseases and Therapy

Melbourne, Australia
August 13-14,2018

Global Experts Meeting on Infectious Diseases

Tokyo,Japan
August 27-28, 2018

9th International Conference on Emerging Infectious Diseases

Zurich, Switzerland
September 17-18, 2018

4th Annual Congress on Infectious Diseases

San Diego, USA
September 27-29, 2018

10thEuro-Global Conference on Infectious Diseases

Rome, Italy

Flu Vaccine: Manufactures & Market Analysis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in